scholarly journals Functional analysis of cell-free RNA using mid-trimester amniotic fluid supernatant in pregnancy with the fetal growth restriction

Medicine ◽  
2018 ◽  
Vol 97 (2) ◽  
pp. e9572
Author(s):  
Hee Young Cho ◽  
Yeonkyung Cho ◽  
Yun-Jeong Shin ◽  
Jieun Park ◽  
Sunghan Shim ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Amniotic Fluid ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
In Pregnancy

Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy

2005 ◽  
Vol 38 (11) ◽  
pp. 1537-1541 ◽  
Author(s):  
Mariangela Longini ◽  
Serafina Perrone ◽  
Antonio Kenanidis ◽  
Piero Vezzosi ◽  
Barbara Marzocchi ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Predictive Marker ◽  
Growth Restriction ◽  
In Pregnancy

The secrets of placental mosaicism: clinical observation of the full form of confined placental trisomy 22 and literature review

2020 ◽  
Author(s):  
I.V. Komarova, A.A. Nikiforenko, A.V. Fedunyak
Keyword(s):  
Prenatal Diagnosis ◽  
Literature Review ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Clinical Observation ◽  
Growth Restriction ◽  
Favorable Outcome ◽  
Full Form ◽  
Placental Mosaicism ◽  
In Pregnancy

Literature reports of placental mosaicism, including trisomy 22, were analyzed. The chance of correlation of placental aneuploidy with fetus aneuploidy, also the probability of complications in pregnancy and fetal growth restriction and postnatal patients growth in the cases of confined placental mosaicism, were demonstrated. The case of prenatal diagnosis of confined placental mosaicism of trisomy 22 with favorable outcome is presented. The necessity of cytogenic assay of amniocytes and fetal lymphocytes in the case of placental heteroploidy diagnosis was emphasized.

scholarly journals 1129 How useful is assessment of amniotic fluid volume in antenatal surveillance of fetal growth restriction?

2021 ◽  
Vol 224 (2) ◽  
pp. S696
Author(s):  
Lauren Sayres ◽  
Camille Driver ◽  
Xinyi Yang ◽  
Mary Sammel ◽  
Heather Straub ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Fluid Volume ◽  
Growth Restriction ◽  
Amniotic Fluid Volume

scholarly journals Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy

2017 ◽  
Vol 595 (15) ◽  
pp. 5095-5102 ◽  
Author(s):  
Elizabeth Cottrell ◽  
Teresa Tropea ◽  
Laura Ormesher ◽  
Susan Greenwood ◽  
Mark Wareing ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Therapeutic Potential ◽  
Growth Restriction ◽  
Dietary Interventions ◽  
Dietary Nitrate ◽  
Nitrate Supplementation ◽  
In Pregnancy

scholarly journals Non-targeted urinary metabolomics in pregnancy and associations with fetal growth restriction

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Chelsea M. Clinton ◽  
James R. Bain ◽  
Michael J. Muehlbauer ◽  
YuanYuan Li ◽  
Leping Li ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
In Pregnancy

T11.1 Association between stillbirth, fetal growth restriction and hypertensive diseases in pregnancy

2010 ◽  
Vol 1 ◽  
pp. S21
Author(s):  
Tony Odibo ◽  
Andre Francis ◽  
Alison Cahill ◽  
Roxanne Rampersad ◽  
George Macones ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
Hypertensive Diseases ◽  
In Pregnancy

scholarly journals Maternal sirolimus therapy and fetal growth restriction

2021 ◽  
Vol 8 (2) ◽  
pp. 19-24
Author(s):  
Sangay Tshering ◽  
Namkha Dorji ◽  
Youden Sonam
Keyword(s):  
Case Report ◽  
Signaling Pathway ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Mtor Signaling ◽  
Growth Restriction ◽  
Mtor Signaling Pathway ◽  
Epigenetic Modulation ◽  
In Pregnancy

Fetal growth restriction associated with continued maternal sirolimus therapy in pregnancy has not been reported. We hereby present a case of maternal sirolimus therapy resulting in fetal growth restriction and propose a multi-hit model. This hypothetic model is based on inhibition of mTOR signaling pathway and epigenetic modulation. This case report adds to the paucity of literature on continued monotherapeutic maternal sirolimus in pregnancy and its adverse fetal effects.

Sign in / Sign up

Export Citation Format

Share Document